Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01426997 · ClinicalTrials.gov registry record
Phenotype Depression Study
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 279
- Enrollment target
NCT01426997 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 279 participants.
The verdict
NCT01426997 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 279 participants
- Enrollment target
Study Summary
To facilitate the development of a personalized approach to the treatment of patients with major depression, this study is designed to elaborate the clinical and neurobiological phenotype of depressed patients with increased inflammation. The data obtained in this proposal will allow the investigators to test the hypothesis that depression and inflammation interact to elaborate a relatively discreet phenotype that warrants an individualized approach to diagnosis and treatment of patients with depression. Moreover, the identification of specific environmental risk factors for inflammation will foster the elaboration of preventative strategies for patients at risk.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2010-07 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01426997
The ClinicalTrials.gov registry entry for NCT01426997 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01426997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01426997 about?
NCT01426997 is a clinical study titled "Phenotype Depression Study". To facilitate the development of a personalized approach to the treatment of patients with major depression, this study is designed to elaborate the clinical and neurobiological phenotype of depressed patients with increased inflammation. The data obtained in this proposal will allow the investigato...
What is the current status of trial NCT01426997?
This trial is currently completed. The enrollment target is 279 participants. The study started on 2010-07. Estimated completion is 2016-05.
Who is sponsoring clinical trial NCT01426997?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.